The purpose of GREAT FUTURES (Genomics for Risk Evaluation and Anticancer Therapy: the Future of Cancer Research. A Comprehensive Biobank and Data Repository to Catalyze Cancer Research) is to establish a comprehensive biobank, genomic sequencing pipeline, and affiliated data warehouse to study the role of genetics in cancer risk and response to therapy in children and adults who have developed cancer, and in families at high risk for cancer development...

This research trial studies the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.

This research trial studies a risk-based classification system for patients with newly diagnosed acute lymphoblastic leukemia. Gathering health information about patients with acute lymphoblastic leukemia may help doctors learn more about the disease and plan the best treatment.

This partially randomized phase III trial studies different combinations of risk-adapted chemotherapy regimens and their side effects and comparing how well they work in treating younger patients with newly diagnosed standard-risk acute lymphoblastic leukemia or B-lineage lymphoblastic lymphoma that is found only in the tissue or organ where it began (localized)...

This randomized phase III trial studies how well combination chemotherapy works in treating young patients with newly diagnosed B acute lymphoblastic leukemia that is likely to come back or spread, and in patients with Philadelphia chromosome (Ph)-like tyrosine kinase inhibitor (TKI) sensitive mutations...

Our representatives are available to schedule your appointment on weekdays from 8am to 8pm and weekends from 9am to 5pm. You may also leave a voicemail message after regular business hours, and we will return your call.